FDA gives OK for schizophrenia treatment
(AP)


AP - AstraZeneca PLC said Monday that it has received approval from the U.S. Food and Drug Administration for a new formulation of its popular Seroquel schizophrenia treatment, making it the first medicine to treat both the manic and depressive sides of bipolar disorder.